A new classification of clinical stages of adult T-cell leukemia based on prognosis of the disease

Leukemia

Volumn 8, Issue 11, 1994, Pages 1834-1837

  Shirono, Kenji ^a   Hattori, Toshio ^b   Takatsuki, Kiyoshi ^c  

^a KUMAMOTO CITY HOSPITAL   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; T LYMPHOCYTE ANTIGEN;

ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER GROWTH; CANCER MORTALITY; CANCER SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROGNOSIS; T CELL LEUKEMIA;

EID: 0027984275     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Takatsuki K, Uchiyama T, Sagawa K, Yodoi J. Adult T cell leukemia in Japan. In: Seno S, Takaku F, Irino S, eds. Topics in hematology. Amsterdam: Excepta Medica, 1977:73-77.
2. Poiesz BJ, Ruscetti FW, Gazder AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980;77:7415-7419.
3. Hattori T, Uchiyama T, Toibana T, Takatsuki K, Uchino H. Surface phenotype of lapanese ATL cells characterized by monoclonal antibodies. Blood 1981;58:645-647.
4. Takatsuki K, Yamaguchi K, Kawano F, Hattori T, Nishimura H, Tsuda H, Sanada I, Nakada K, Itai Y. Clinical diversity in adult T-cell leukemia-lymphoma. Cancer Res 1985;45:4644-4645.
5. Kawano F, Yamaguchi K, Nishimura H, Tsuda H, Takatsuki K. Variation in the clinical courses of adult T-cell leukemia. Cancer 1985;55:851-860.
6. Shimoyama M, and members of the Lymphoma Study Group (1984-1987). Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. Br J Haematol 1991;79:428-437.
7. Shirono K, Hattori T, Hata H, Nishimura H, Takatsuki K. Profiles of expression of activated cell antigens on peripheral blood and lymph node cells from different clinical stages of adult T cell leukemia. Blood 1989;73:1664-1671.
8. Shirono K, Hattori T, Takatsuki K. Prognostic usefulness of Ki-67 antigen expression in adult T-cell leukaemia. Lancet 1989;ii:1044.
9. Gerdes J, Schwab U, Lemke H, Stein H. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 1983;31:13-20.
10. Yamada Y, Murata K, Kamihira S, Atogami S, Tsukasaki K, Sohda H, Yanagisako T, Momita S, Jubashi T, Amagasaki T, Kuriyama K, Oyakawa Y, Tagawa M, Konosita KI, Ichimaru M, Tomonaga M. Prognostic significance of the proportion of Ki-67-positive cells in adult T-cell leukemia. Cancer 1991;67:2605-2609.
11. Shirono K, Hattori T, Matsuoka M, Matsushita S, Asou N, Takatsuki K. Adult T cell leukemia cell lines that originated from primary leukemic clones also had a defect of expression of CD3-T cell receptor complex. Leukemia 1988;2:728-733.
12. Schwarting R, Gerdes J, Niehus J, Jaeschke L, Stein H. Determination of the growth traction in cell suspensions by flow cytometry using the monoclonal antibody Ki-67. J Immunol Methods 1986;90:65-70.
13. Kaplan EL, Meier P. Nonparametric estimation from incomplete observation. J Am Stat Assoc 1958;53:457-481.
14. Gehan E. A generalized Wilcoxon test for comparing arbitrarily singly-censored samples. Biometrika 1965;52:203-223.
15. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966;50:163-170.
16. Gerdes J, Lemke H, Baisch H, Wacher HH, Schwab U, Stein H. Cell cycle analysis of a cell proliferating-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984;133:1710-1715.
17. Gerdes J, Dallenbach F, Lennert K, Lemke H, Stein H. Growth tractions in malignant non-Hodgkin's lymphomas (NHL) as determined in situ with the monoclonal antibody Ki-67. Hematol Oncol 1984;2:365-371.
18. Ralfkiaer E, Stein H, Bosq J, Gatter KC, Ralfkiaer N, Wantzin GL, Mason DY. Expression of a cell-cycle-associated nuclear antigen (Ki-67) in cutaneous lymphoid infiltrates. Am J Dermatopathol 1986;8:37-43.
19. Grogan TM, Lippman SM, Spier CM. Independent prognostic significance of a nuclear proliferation antigen in diffuse large cell lymphomas as determined by the monoclonal antibody Ki-67. Blood 1988;71:1157-1160.
20. Sasaki K, Matsumura K, Tsuji T, Shinozaki F, Takahashi M. Relationship between labeling indices of Ki-67 and GrdUrd in human malignant tumors. Cancer 1988;62:989-993.
21. Hall PA, Richards MA, Gregory WM, d'Ardenne AJ, Lister TA, Stansfeld AG. The prognostic value of Ki-67 immunostaining in non-Hodgkin's lymphoma. J Pathol 1988;154:223-235.
22. Ueda T, Aozasa K, Tsujimoto M. Prognostic significance of Ki-67 reactivity in soft tissue sarcomas. Cancer 1989;63:1607-1611.
23. Wintzer HO, Zipfel I, Schulte MJ, Hellerich U, von Kleist S. Ki-67 immunostaining in human breast tumors and its relationship to prognosis. Cancer 1991;67:421-428.
24. Nakano T, Oka K. Differential values of Ki-67 index and mitotic index of proliferating cell population. Cancer 1993;72:2401-2408.